Cleared Traditional

K131358 - BD PEN NEEDLE

K131358 is an FDA 510(k) clearance for BD PEN NEEDLE, manufactured by Becton, Dickinson & CO. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 67-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
67d
Days
Class 2
Risk

K131358 is an FDA 510(k) clearance for the BD PEN NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Becton, Dickinson & CO (Franklin Lakes, US). The FDA issued a Cleared decision on July 16, 2013 after a review of 67 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Becton, Dickinson & CO devices

FDA 510(k) Submission Details - K131358

510(k) Number K131358 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2013
Decision Date July 16, 2013
Days to Decision 67 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 129d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 271
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K131358.
K-Pack II Needle-21G x 2
K150263 · Terumo Europe N.V. · Apr 2015
K-PACK II NEEDLE - 27G X 3/4 THIN WALL
K132233 · Terumo Europe N.V. · Sep 2013
STERICAN CANNULA
K131842 · B.Braun Medical, Inc. · Aug 2013
BD PEN NEEDLE
K123300 · Becton, Dickinson & CO · Jan 2013
NIPRO HUBER INFUSION, EXCEL HUBER NEEDLE
K113469 · Nipro Medical Corporation · Oct 2012
27 G X 1/2 K-PACK SURSHIELD NEEDLE
K111797 · Terumo Europe N.V. · Sep 2011